Bladder cancer

Introduction

Bladder cancer is the ninth most common cancer type worldwide. In 2022, more than 600 000 people were diagnosed with bladder cancer worldwide and more than 220 000 people died from the disease. Bladder cancer is one of the most challenging and expensive cancers to diagnose and treat. Its diagnosis relies mainly on cystoscopy, an invasive and expensive procedure. Most bladder cancers are diagnosed at an early stage, when they are highly treatable. However, about 25% of bladder cancers are diagnosed at later stages.

News & Events

News

IARC Monographs evaluate the carcinogenicity of talc and acrylonitrile: IARC Monographs Volume 136

Press Releases

Press Release

IARC Monographs evaluate the carcinogenicity of talc and acrylonitrile IARC Monographs Volume 136

Go to PDF 05.07.2024

01.07.2022 IARC Monographs evaluate the carcinogenicity of occupational exposure as a firefighter

20.05.2022 Promising urine test could improve early detection and clinical management of bladder cancer: IARC Evidence Summary Brief No. 3

SEE MORE Press Releases

Highlights

IARC Monographs evaluate the carcinogenicity of talc and acrylonitrile: IARC Monographs Volume 136

Videos

Recording

Bladder Cancer Awareness Month: Dr Florence Le Calvez-Kelm & Dr Mahdi Sheikh on promising biomarkers

WATCH VIDEO 31.05.2021

SEE MORE Videos

Infographics

Infographic

IARC Monographs evaluation of the carcinogenicity of talc and acrylonitrile

IARC Monographs evaluate the carcinogenicity of occupational exposure as a firefighter

1. What are the results of the evaluation?

2. Has this agent previously been evaluated by the IARC Monographs programme?

3. Why was occupational exposure as a firefighter re-evaluated?

09.10.2020 IARC Monographs evaluate the carcinogenicity of opium consumption
Questions and Answers (Q&A)

SEE MORE Q&As

Research Project Websites

Bladder Cancer Epidemiology and Early Detection in Africa (BEED) study Global Cancer Observatory